1 / 15

Using Random Peptide Phage Display L ibraries for early Breast cancer detection

Using Random Peptide Phage Display L ibraries for early Breast cancer detection. Ekaterina Nenastyeva. OUTLINE. Introduction Motivation for early cancer detection State of the art Proposed assay based on Random Peptide Phage Display Libraries and Next Generation sequencing Data Set

duy
Download Presentation

Using Random Peptide Phage Display L ibraries for early Breast cancer detection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Using Random Peptide Phage Display Libraries forearly Breast cancer detection Ekaterina Nenastyeva

  2. OUTLINE • Introduction • Motivationfor early cancer detection • State of the art • Proposed assay based on Random Peptide Phage Display Libraries and Next Generation sequencing • Data Set • Data preprocessing • Approaches for early Breast cancer detection • Identification of peptides specific for Breast cancer • Discrimination based on the whole peptide library • Results and evaluation • LOO cross-validation • Permutation test • Future work • Enriching library by cancer specific peptides • PCA

  3. Motivation for early cancer detection • Earlier stages   Simpler/ more effective treatment • Promising earlier stage biomarkers: Antibodies

  4. State of the art The current methods of analysis of antitumor humoralimmune response: • SEREX • SERPA • ELISA • Antigen microarrays • Random peptide microarrays

  5. Any antigen can be substituted by a library of random peptides c N E F E P C K V A Q D D L R A Y F W R P Peptide A peptide sequence can mimic the epitope recognized by an antibody Phage envelop Peptide coding sequence Phage DNA

  6. Detailed assay

  7. Data Set 10 samples: • 5 cases = stage 0 breast cancer patients • 5 controls = cancer-free women Each sample = 2 replicas Each replica has • Number of distinct 7-mer peptides • Total number of peptides in a replica:  normalization  Total number of distinct 7-mer peptides in all replicas controls cases

  8. Approaches for early Breast cancer detection • Identification of peptides specific for Breast cancer • Discrimination based on the whole list of peptides

  9. Discrimination based on specific peptides • Cancer specific peptides: • Control specific peptides: controls cases MAX < MIN controls cases MIN > MAX

  10. Peptides specific for Breast cancer 7-mers: 1; 6-mers: 9; 5-mers: 44 (There are no control specific peptides!)

  11. Permutation test for discrimination based on specific peptides Hypothesis: “Controls do not have any peptide distinguishing them from cases, and cases have no less than one 7-mer, nine 6-mer and forty four 5-mer specific peptides” • Permutation test: • permutations • P-value = 0.028

  12. Discrimination based on the whole peptide library • AVG correlation: • Threshold : • (0.12+0.03)/2=0.075 • Correlation between peptides assigned to cases is higher than between controls IF AVG correlation:  case OTHERWISE  control

  13. Leave-one-out cross-validation for discrimination based on correlation • Sensitivity =0.8 (4/5 correct predicted cases) • Specificity =1 (5/5 correct predicted controls) • Accuracy = 0.9 Permutation test for leave-one-out • permutations • 5 permutations have accuracy 0.9 (includingtrue statuses arrangement) • P-value = 0.02 controls A,B,C,E,H cases D,F,G,I,J

  14. Conclusion • Discrimination method based on whole peptide library and correlation showed statistically significant results • Found Breast cancer specific peptides were not statistically significant although the hypothesis that there were no peptides specific for controls was statistically significant

  15. Future work Discrimination methods based on: • Correlation and enriching library by cancer specific peptides • Principal component analysis 

More Related